Literature DB >> 313733

Hereditary C2 deficiency associated with common variable immunodeficiency.

M Seligmann, J C Brouet, M Sasportes.   

Abstract

Homozygous C2 deficiency in a 19-year-old boy was associated with variable immunodeficiency manifested by marked hypoimmunoglobulinemia and impaired antibody responses, normal circulating B lymphocytes, and subnormal T-cell functions. Neither antilymphocytic autoantibodies nor chromosomal abnormalities were found. Serum immunoglobulin levels were within normal limits in his parents and brother who were heterozygous for C2 deficiency. The patient's lymphocytes were homozygous at the HLA-D locus but expressed an antigen different from DW2.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 313733     DOI: 10.7326/0003-4819-91-2-216

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  4 in total

Review 1.  Lupus diseases associated with hereditary and acquired deficiencies of complement.

Authors:  V Agnello
Journal:  Springer Semin Immunopathol       Date:  1986

2.  Recurrent pyogenic infections in individuals with absence of the second component of complement.

Authors:  H A Sampson; A M Walchner; P J Baker
Journal:  J Clin Immunol       Date:  1982-01       Impact factor: 8.317

3.  Immunoglobulin deficiencies and susceptibility to infection among homozygotes and heterozygotes for C2 deficiency.

Authors:  Chester A Alper; Jianhua Xu; Katherine Cosmopoulos; Brian Dolinski; Rosanne Stein; Gabriel Uko; Charles E Larsen; Devendra P Dubey; Peter Densen; Lennart Truedsson; Gunnar Sturfelt; Anders G Sjöholm
Journal:  J Clin Immunol       Date:  2003-07       Impact factor: 8.317

4.  Hereditary Deficiency of the Second Component of Complement: Early Diagnosis and 21-Year Follow-Up of a Family.

Authors:  Rosa Maria Dellepiane; Lucia Augusta Baselli; Marco Cazzaniga; Vassilios Lougaris; Paolo Macor; Mara Giordano; Roberta Gualtierotti; Massimo Cugno
Journal:  Medicina (Kaunas)       Date:  2020-03-10       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.